Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Myths and realities of antiemetic treatment.

Literature DB >> 1467202

Myths and realities of antiemetic treatment.

M Martin¹.

Abstract

Mesh：

Substances：

Year: 1992 PMID： 1467202 PMCID： PMC2149635

Source DB: PubMed Journal: Br J Cancer Suppl ISSN： 0306-9443

× No keyword cloud information.

21 in total

1. Letter: Cancer treatment needs better antiemetics.

Authors: V M Whitehead
Journal: N Engl J Med Date: 1975-07-24 Impact factor: 91.245

2. Laparotomic eventration or colonic prolapse after chemotherapy-induced emesis.

Authors: M Martin-Jimenez; E Diaz-Rubio; B Sangro; R Marote
Journal: J Surg Oncol Date: 1988-03 Impact factor: 3.454

3. [Evaluation of an antiemetic regimen with a high-dose metoclopramide, dexamethasone and diphenhydramine combination in chemotherapy regimens with cisplatin].

Authors: A Abad-Esteve; R Rosell; I Moreno; P Monrás; C Fernández; M Serichol; M Clotet; M Ribas Mundó
Journal: Med Clin (Barc) Date: 1986-12-06 Impact factor: 1.725

4. A comparison of the antiemetic effects of droperidol and prochlorperazine in chemotheray with cis-platinum.

Authors: A J Jacobs; G Deppe; C J Cohen
Journal: Gynecol Oncol Date: 1980-08 Impact factor: 5.482

5. Therapy-linked leukemia.

Authors: J Chang; C G Geary
Journal: Lancet Date: 1977-01-08 Impact factor: 79.321

6. High-dose metoclopramide: control of dacarbazine-induced emesis in a preliminary trial.

Authors: L B Tyson; R A Clark; R J Gralla
Journal: Cancer Treat Rep Date: 1982-12

7. Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.

Authors: M G Kris; R J Gralla; R A Clark; L B Tyson; J P O'Connell; M S Wertheim; D P Kelsen
Journal: J Clin Oncol Date: 1985-10 Impact factor: 44.544

8. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study.

Authors: B I Carr; M Bertrand; S Browning; J H Doroshow; C Presant; B Pulone; L R Hill
Journal: J Clin Oncol Date: 1985-08 Impact factor: 44.544

Myths and realities of antiemetic treatment.

1. Letter: Cancer treatment needs better antiemetics.

2. Laparotomic eventration or colonic prolapse after chemotherapy-induced emesis.

3. [Evaluation of an antiemetic regimen with a high-dose metoclopramide, dexamethasone and diphenhydramine combination in chemotherapy regimens with cisplatin].

4. A comparison of the antiemetic effects of droperidol and prochlorperazine in chemotheray with cis-platinum.

5. Therapy-linked leukemia.

6. High-dose metoclopramide: control of dacarbazine-induced emesis in a preliminary trial.

7. Incidence, course, and severity of delayed nausea and vomiting following the administration of high-dose cisplatin.

8. A comparison of the antiemetic efficacy of prochlorperazine and metoclopramide for the treatment of cisplatin-induced emesis: a prospective, randomized, double-blind study.

9. Prognostic factors influencing cisplatin-induced emesis. Definition and validation of a predictive logistic model.

10. The course of nausea and vomiting after high-dose cyclophosphamide.

1. Acute and anticipatory emesis in breast cancer patients.

2. Patient perceptions of the side-effects of chemotherapy: the influence of 5HT3 antagonists.

3. The validation of a newly developed Arabic scale to assess patient-reported side-effects of antineoplastic agents.